Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies

Pancreatic cancer will be positioned by the year 2030 as the second cause of oncological death after lung cancer. The pathophysiology of the most common variety, which involves the adenocarcinoma of the pancreas, represents one of the main challenges for current oncology to explain its tumorigenesis...

Descripción completa

Detalles Bibliográficos
Autores principales: Ortega, Miguel A., Pekarek, Leonel, Fraile-Martinez, Oscar, Garcia-Montero, Cielo, Saez, Miguel A., Asúnsolo, Angel, Alvarez-Mon, Miguel A., Monserrat, Jorge, Ruiz-Llorente, Lidia, García-Honduvilla, Natalio, Albillos, Agustin, Buján, Julia, Alvarez-Mon, Melchor, Guijarro, Luis G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027548/
https://www.ncbi.nlm.nih.gov/pubmed/35448172
http://dx.doi.org/10.3390/curroncol29040198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9027548/
https://www.ncbi.nlm.nih.gov/pubmed/35448172
http://dx.doi.org/10.3390/curroncol29040198

Ejemplares similares